EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)

Shuji Asai iD, Mochihito Suzuki, Ryota Hara, Yuji Hirano, Satomi Nagamine, Tetsuya Kaneko, Takahito Suto, Tadashi Okano, Yutaka Yoshioka, Makoto Hirao, Hiroki Wakabayashi, Takayoshi Fujibayashi und 17 weitere

Modern Rheumatology · 20.08.2024 · 34 (5) · 892-899

DOI: 10.1093/mr/roae027 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Rheumatology, online erschienen am 06.03.2024. Verfasst von Shuji Asai und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Age of Onset, Antirheumatic Agents, Arthritis, Rheumatoid, Methotrexate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effectiveness of methotrexate (MTX) as initial therapy in patients with late-onset and younger-onset rheumatoid arthritis (LORA and YORA).

Methods

Of 114 patients with YORA and 96 patients with LORA, defined as RA occurring at ≥65 years of age, enrolled in a multicentre RA inception cohort study, 71 and 66 patients who had been followed up to 6 months after starting MTX treatment were included in this study.

Results

Proportions of patients on MTX treatment at 6 months were 96% and 92% in the YORA and LORA groups, respectively. Despite lower doses of MTX in the LORA group compared with the YORA group, no significant difference was observed in clinical disease activity index scores between the two groups throughout the follow-up period. The proportion of patients in clinical disease activity index remission at 6 months was 35% in both groups. Logistic regression analysis revealed that knee joint involvement and high Health Assessment Questionnaire-Disability Index were significant negative predictors of achieving clinical disease activity index remission at 6 months in the LORA group.

Conclusion

Observations up to 6 months revealed that the effectiveness of MTX administered based on rheumatologist discretion in patients with LORA is comparable to that in patients with YORA in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Age of OnsetAntirheumatic AgentsArthritis, RheumatoidMethotrexateAgedHumansCohort StudiesJapanRemission InductionSeverity of Illness IndexTreatment OutcomeMaleFemaleAdultMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Agedlate-onset disordersmethotrexateremissionrheumatoid arthritis

Substanzen

Antirheumatic AgentsMethotrexate

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Rheumatology, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
  • Department of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
  • Department of Orthopedic Surgery, Japan Red Cross Society Fukaya Red Cross Hospital, Fukaya, Saitama, Japan.
  • Department of Orthopedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

ORCID-Profile: Shuji Asai

Zitieren

APA

Asai, S., Suzuki, M., Hara, R., Hirano, Y., Nagamine, S., Kaneko, T., Suto, T., Okano, T., Yoshioka, Y., Hirao, M., Wakabayashi, H., Fujibayashi, T., Watanabe, T., Takakubo, Y., Ishikawa, H., Nasu, Y., Takemoto, T., Kato, T., Torikai, E., …, & Imagama, S. (2024). Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J). Modern Rheumatology, 34(5), 892-899. https://doi.org/10.1093/mr/roae027

Vancouver

Asai S, Suzuki M, Hara R, Hirano Y, Nagamine S, Kaneko T, et al. Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J). Modern Rheumatology. 2024;34(5):892-899. doi:10.1093/mr/roae027

BibTeX
@article{Asai2024,
  author = {Asai, Shuji and Suzuki, Mochihito and Hara, Ryota and Hirano, Yuji and Nagamine, Satomi and Kaneko, Tetsuya and Suto, Takahito and Okano, Tadashi and Yoshioka, Yutaka and Hirao, Makoto and Wakabayashi, Hiroki and Fujibayashi, Takayoshi and Watanabe, Tatsuo and Takakubo, Yuya and Ishikawa, Hajime and Nasu, Yoshihisa and Takemoto, Toki and Kato, Takefumi and Torikai, Eiji and Koyama, Kensuke and Takagi, Hideki and Fujiwara, Toshifumi and Sobue, Yasumori and Ohashi, Yoshifumi and Nishiume, Tsuyoshi and Terabe, Kenya and Kojima, Masayo and Kojima, Toshihisa and Imagama, Shiro},
  title = {Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)},
  journal = {Modern Rheumatology},
  year = {2024},
  volume = {34},
  number = {5},
  pages = {892--899},
  doi = {10.1093/mr/roae027}
}
Kostenlos starten →